Berks Hematology Oncology — West Reading, Pennsylvania

Berks Hematology Oncology is a clinical research site located in West Reading, Pennsylvania, United States 19611.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Berks Hematology Oncology has participated in 3 clinical trials.

Therapeutic areas: Breast Cancer, First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Sponsors: Novartis Pharmaceuticals, Puma Biotechnology, Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Berks Hematology Oncology?

Berks Hematology Oncology has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Berks Hematology Oncology conducted?

Berks Hematology Oncology has 3 clinical trials on record. Their work covers Breast Cancer, First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Is Berks Hematology Oncology accredited by Crixeo Health?

Berks Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Berks Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.